hypoxanthine has been researched along with Parkinson Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, T; Ito, T; Johnson, TA; Kamatani, N; Kamitsuji, S; Koike, Y; Kume, A; Misu, K; Sobue, G; Watanabe, H | 1 |
| Aasly, JO; Beal, MF; Bogdanov, M; Henchcliffe, C; Johansen, KK; Matson, WR; Wang, L; White, LR | 1 |
| Daniel, SE; Halliwell, B; Jenner, P; Lees, AJ; Marsden, DC; Spencer, JP | 1 |
| Camp, DM; Harel, E; Juneau, PL; LeWitt, PA; Loeffler, DA | 1 |
| Kawachi, M; Kiyokawa, H; Kono, N; Kuwajima, M; Mineo, I; Nakajima, H; Shimizu, T; Tarui, S; Yorifuji, S | 1 |
1 trial(s) available for hypoxanthine and Parkinson Disease
| Article | Year |
|---|---|
Improved Parkinsons disease motor score in a single-arm open-label trial of febuxostat and inosine.
Topics: Adenosine Triphosphate; Administration, Oral; Aged; Case-Control Studies; Drug Therapy, Combination; Febuxostat; Female; Gout Suppressants; Humans; Hypoxanthine; Inosine; Japan; Male; Middle Aged; Nervous System Diseases; Parkinson Disease; Safety; Treatment Outcome; Xanthine Dehydrogenase | 2020 |
4 other study(ies) available for hypoxanthine and Parkinson Disease
| Article | Year |
|---|---|
Metabolomic profiling in LRRK2-related Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Gene Expression Regulation; Humans; Hypoxanthine; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Metabolomics; Middle Aged; Mutation; Parkinson Disease; Protein Serine-Threonine Kinases; Uric Acid | 2009 |
Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.
Topics: 3,4-Dihydroxyphenylacetic Acid; 8,11,14-Eicosatrienoic Acid; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Copper; Cysteine; Dihydroxyphenylalanine; Dopamine; Glutathione; Humans; Hypoxanthine; Iron; Parkinson Disease; Reactive Oxygen Species; Reference Values; Superoxides; Xanthine | 1998 |
Purine-induced alterations of dopamine metabolism in rat pheochromocytoma PC12 cells.
Topics: Adenine; Adenosine; Animals; Disease Models, Animal; Dopamine; Guanine; Guanosine; Hypoxanthine; Neostriatum; Neural Pathways; Neurons; Parkinson Disease; PC12 Cells; Purines; Rats; Substantia Nigra; Uric Acid; Xanthine | 2000 |
Decreased renal clearance of xanthine and hypoxanthine in a patient with renal hypouricemia: a new defect in renal handling of purines.
Topics: Humans; Hypoxanthine; Hypoxanthines; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Parkinson Disease; Probenecid; Pyrazinamide; Uric Acid; Xanthine; Xanthines | 1992 |